|
Levofloxacin Impurity 4
|
左氧氟沙星雜質(zhì)4
|
117620-85-6
|
|
Levofloxacin Impurity 2
|
左氧氟沙星雜質(zhì)2
|
1346603-62-0
|
|
Dehydroglyasperin C
|
去氫粗毛甘草素C
|
199331-35-6
|
|
Atorvastatin Impurity 60
|
阿托伐他汀鈣雜質(zhì)60
|
693793-87-2
|
|
Dydrogesterone Impurity C
|
地屈孕酮雜質(zhì)C
|
246038-13-1
|
|
Zopiclone N-Oxide CAS：43200-96-0
|
N-氧化佐匹克隆雜質(zhì)
|
43200-96-0
|
|
Lifitegrast Impurity 9
|
立他司特雜質(zhì)9
|
2271299-08-0
|
|
Fenofibrate Impurity G
|
非諾貝特雜質(zhì)G
|
217636-48-1
|
|
Cinacalcet Impurity K
|
西那卡塞雜質(zhì)K
|
2200269-28-7
|
|
Levofloxacin Impurity 1
|
左氧氟沙星雜質(zhì)1
|
117707-40-1
|
|
Dyclonine Impurity 19
|
達克羅寧雜質(zhì)19
|
109556-17-4
|
|
3-Hydroxy-7,12-diketocholanoic acid
|
熊去氧膽酸201-Z4
|
517-33-9
|
|
Allopurinol Impurity F
|
別嘌醇雜質(zhì)F
|
321571-07-7
|
|
Desbutyl Dronedarone Hydrochloride
|
鹽酸決奈達隆雜質(zhì)1
|
141626-35-9
|
|
Lurasidone ImpurityG
|
鹽酸魯拉西酮雜質(zhì)LZ003-G
|
1318074-27-9
|
|
(L)-Dehydroascorbic acid
|
（L）-脫氫抗壞血酸
|
490-83-5
|
|
D-Glucitol, 6-(4-hydroxybenzoate)
|
丙戊酸鈉雜質(zhì)3 6-(4-羥基苯甲酸)-D-葡萄糖醇
|
334948-52-6
|
|
N-Nitroso Sertraline
|
N-亞硝基舍曲林
|
3006789-98-3
|
|
Dobutamine EP Impurity C HCl
|
鹽酸多巴酚丁胺EP雜質(zhì)C
|
51062-14-7
|
|
15(R)-trans-Latanoprost
|
15(R)-反式拉坦前列素
|
913258-34-1
|
|
Clindamycin phosphate
|
克林霉素磷酸酯-α-酰胺
|
1800297-64-6
|
|
Repaglinide Impurity E
|
瑞格列奈雜質(zhì)E
|
147852-26-4
|
|
Hyoscine Butylbromide EP Impurity E
|
丁溴酸東莨菪堿雜質(zhì)E
|
22235-98-9
|
|
Bempedoic Acid Impurity 5
|
貝派度酸雜質(zhì)5
|
413624-71-2
|
|
Epinephrine Impuirty E
|
腎上腺素雜質(zhì)E
|
317351-39-6
|
|
(R)-Pomalidomide
|
(R)-泊馬度胺
|
202271-90-7
|
|
Estradiol Impurity II
|
雌二醇雜質(zhì)II
|
68969-90-4
|
|
Bempedoic Acid Impurity 20
|
貝派度酸雜質(zhì)20
|
738606-64-9
|
|
Mirabegron Impurity HD1927-3133
|
米拉貝隆HD1927-3133
|
2489747-26-2
|
|
Bupropion Related Compound F
|
安非他酮雜質(zhì)F
|
857233-13-7
|
|
(R,S)-Palonosetron Hydrochloride
|
（R，S）鹽酸帕諾洛司瓊
|
135755-51-0
|
|
Levofloxacin Impurity 10
|
左氧氟沙星雜質(zhì)10
|
178912-62-4
|
|
Fenofibrate Impurity F
|
非諾貝特雜質(zhì)F
|
154356-96-4
|
|
Cinacalcet Impurity H
|
西那卡塞雜質(zhì)H
|
21172-43-0
|
|
Bendamustine Impurity
|
苯達莫司汀雜質(zhì)HP3
|
1391052-61-1
|
|
Budenoside EP Impurity H
|
布地奈德EP雜質(zhì)H
|
313474-58-7
|
|
Norepinephrine Bitartrate
|
重酒石酸去甲腎上腺素異構(gòu)體
|
636-88-4
|
|
Norepinephrine Tartrate Impurity
|
去甲腎上腺素磺化物
|
24159-36-2
|
|
Clavulanic acid Impurity
|
克拉維-2-羧酸鉀
|
2196185-67-6
|
|
N-(4-chlorophenyl)hydroxylamine
|
4-氯苯基羥胺
|
823-86-9
|
|
Valsartan EP Impurity C
|
纈沙坦EP雜質(zhì)C
|
952652-79-8
|
|
Atorvastatin Photo degradation Product
|
阿托伐他汀光降解產(chǎn)物
|
873950-19-7
|
|
Ezetimibe Impurity
|
依折麥布3-氟苯衍生物
|
1700622-06-5
|
|
Lenvatinib Impurity LFS-F
|
樂伐替尼雜質(zhì)LFS-F
|
2110414-05-4
|
|
Fenofibrate Impurity E
|
非諾貝特雜質(zhì)E
|
42019-08-9
|
|
Gadobutrol Impurity I
|
釓布醇雜質(zhì)I
|
214195-92-3
|
|
Clofazimine Impurity LFQM10
|
氯法齊明雜質(zhì)LFQM10
|
174884-06-1
|
|
Cefditoren Pivoxil Open Ring Impurity
|
頭孢妥侖四酯開環(huán)雜質(zhì)
|
2409806-43-3
|
|
Azelastine N-Oxide A
|
氮卓斯汀氮氧化物A
|
1346617-18-2
|
|
Palbociclib Impurity 10
|
帕柏西利雜質(zhì)10
|
571190-22-2
|
|
Pentazocine Impurity 1
|
噴他佐辛雜質(zhì)1
|
865-58-7
|
|
Entecavir Impurity 55
|
恩替卡韋雜質(zhì)55
|
1661867-19-1
|
|
(S)-Pomalidomide
|
(S)-泊馬度胺
|
202271-89-4
|
|
Palbociclib Impurity 11
|
帕柏西利雜質(zhì)11
|
2204863-06-7
|
|
Bedaquiline Impurity 14
|
貝達喹啉雜質(zhì)SCR-6063
|
654654-93-0
|
|
Fenofibrate Impurity D
|
非諾貝特雜質(zhì)D
|
42019-07-8
|
|
N,N'-BIS-(4-CHLORO-PHENYL)-HYDRAZINE
|
N,N'-雙-(4-氯-苯基)-肼
|
953-14-0
|
|
Ibuprofen Impurity M
|
布洛芬雜質(zhì)M
|
60057-62-7
|
|
Triamterene Impurity B
|
氨苯蝶啶雜質(zhì)B
|
19375-89-4
|
|
Lurasidone Impurity B
|
鹽酸魯拉西酮雜質(zhì)LZ003-B
|
1318074-18-8
|
|
2-isopropylpentanoic acid（Sodium Valproate Impurity C）
|
2-異丙基戊酸(丙戊酸鈉雜質(zhì)C)
|
62391-99-5
|
|
POLYDIMETHYLSILOXANE
|
西甲硅油對照品
|
8050-81-5
|
|
Atorvastatin Impurity 61
|
阿托伐他汀鈣雜質(zhì)61
|
472967-95-6
|
|
Levofloxacin Impurity 8
|
左氧氟沙星雜質(zhì)8
|
177472-30-9
|
|
Valsartan Impurity 12
|
沙庫巴曲雜質(zhì)12
|
149709-58-0
|
|
Levofloxacin Impurity 6
|
左氧氟沙星雜質(zhì)6
|
100986-89-8
|
|
Atorvastatin Impurity 58
|
阿托伐他汀鈣雜質(zhì)58
|
1116118-82-1
|
|
Cefditoren Pivoxil Impurity P16
|
頭孢托侖匹酯開環(huán)二聚體(P16)
|
2410655-60-4
|
|
Atorvastatin Impurity 59
|
阿托伐他汀鈣雜質(zhì)59
|
1105067-91-1
|
|
Mosapride citrate Impurity C
|
枸櫞酸莫沙必利雜質(zhì)B
|
1215825-20-9
|
|
Methocarbamol B-Isomer
|
美索巴莫B異構(gòu)體
|
10488-39-8
|
|
Desfluoro Ezetimibe
|
脫氟依折麥布
|
302781-98-2
|
|
Sarpogrelate Metabolite 1
|
沙格雷酯中間體1
|
1140968-46-2
|
|
Tenofovir Impurity 4
|
替諾福韋雜質(zhì)4
|
851456-00-3
|
|
Ligustilide
|
藁本內(nèi)酯
|
4431-01-0
|
|
Docetaxel Impurity
|
多西他賽雜質(zhì)
|
153744-63-9
|
|
Metaraminol Bitartrate Impurity D
|
重酒石酸間羥胺雜質(zhì)D
|
21480-43-3
|
|
Bempedoic Acid Impurity F
|
貝派度酸雜質(zhì)F
|
2570179-40-5
|
|
Levofloxacin Impurity 5
|
左氧氟沙星雜質(zhì)5
|
100986-86-5
|
|
Fenoterol EP Impurity A
|
非諾貝特EP雜質(zhì)A
|
107878-38-6
|
|
Estradiol Impurity I
|
雌二醇雜質(zhì)I
|
4966-70-5
|
|
Adagrasib Impurity
|
頭孢唑肟雜質(zhì)
|
5407-04-5
|
|
Fenofibrate Impurity C
|
非諾貝特雜質(zhì)C
|
217636-47-0
|
|
Azelastine N-Oxide B
|
氮卓斯汀氮氧化物B
|
1346617-06-8
|
|
Ezetimibe ImpurityQ
|
依折麥布雜質(zhì)Q
|
190595-66-5
|
|
Triethylenethiophosphoramide 1
|
塞替派雜質(zhì)1
|
90877-51-3
|
|
MelatoninImpurity 5
|
褪黑素雜質(zhì)5
|
188397-16-2
|
|
Estradiol Impurity 2
|
雌二醇雜質(zhì)2
|
4954-08-9
|
|
Gadobutrol Impurity II
|
釓布醇雜質(zhì)II
|
214196-05-1
|
|
Estradiol Impurity V
|
雌二醇雜質(zhì)V
|
50394-95-1
|
|
Cefditoren Pivoxil Impurity 13
|
甲氧甲基頭孢托侖匹酯
|
2762536-15-0
|
|
Azvudine Impurity C19040112-S1-IM38
|
阿茲夫定雜質(zhì)C19040112-S1-IM38
|
1596289-55-2
|
|
Estradiol Impurity III
|
雌二醇雜質(zhì)III
|
4011-48-7
|
|
Clemastine Fumarate EP Impurity B
|
富馬酸氯馬斯汀雜質(zhì)B
|
1352549-49-5
|
|
L-dihydrophenylglycine methyl ester
|
L-雙氫苯甘氨酸甲酯
|
|
|
Pinaverium Bromide Impurity 14
|
匹維溴銨雜質(zhì)14
|
1970218-63-3
|
|
Methylparaben Impurity 30
|
羥苯甲酯雜質(zhì)30
|
335096-48-5
|
|
Ezetimibe o-Fluorobenzene Isomer
|
依折麥布2-氟苯異構(gòu)體
|
2743547-96-6
|
|
Paraben Impurity 2
|
尼泊金甲酯雜質(zhì)2
|
953507-76-1
|
|
Eplerenone Impurity36
|
依普利酮雜質(zhì)36
|
910107-80-1
|